Spasticity and Its Contribution to Hypertonia in Cerebral Palsy

Spasticity is considered an important neural contributor to muscle hypertonia in children with cerebral palsy (CP). It is most often treated with antispasticity medication, such as Botulinum Toxin-A. However, treatment response is highly variable. Part of this variability may be due to the inability...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biomed Res Int
Autors principals: Bar-On, Lynn, Molenaers, Guy, Aertbeliën, Erwin, Van Campenhout, Anja, Feys, Hilde, Nuttin, Bart, Desloovere, Kaat
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2015
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4306250/
https://ncbi.nlm.nih.gov/pubmed/25649546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/317047
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars